NEUROLOGICAL AND PSYCHONEUROLOGICAL MANIFESTATIONS IN COVID 19 PATIENTS
Abstract
The article presents a review of scientific literature, clinical observations, containing data on the features of neurological manifestations and mental disorders, complications from the nervous system in a new coronavirus infection, illustrated with clinical examples. Neurological manifestations are not leading in the clinic for diseases caused by coronaviruses. However, the development of the nervous system is also possible with respiratory, sensory, motor, autonomic and other disorders of the central and peripheral nervous system. In addition, COVID-19 can worsen the course of already existing neurological diseases, therefore, this article provides basic recommendations for the management of certain groups of patients with nervous diseases. Given the earlier epidemics of other coronavirus infections, neurologists most often face cognitive and psycho-emotional disorders and other pathologies in the subsequent period. Therefore, it is important to choose the appropriate treatment and monitor the development of early and long-term consequences of neurological manifestations and complications of COVID-19 and then evaluate the effectiveness of effective individual rehabilitation programs for patients.
Keywords
Covid 19,, nervous system, neurological symptomsHow to Cite
References
Vremennyye metodicheskiye rekomendatsii. Profilaktika, diagnostika i lecheniye novoy koronavirusnoy infektsii (COVID-19). Versiya 6. Aprel' 28, 2020. Ministerstvo zdravookhraneniya Rossiyskoy Federatsii. [Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 6; April 28, 2020. Ministry of Health of the Russian Federation. In Russian].
Pérez CA. Looking ahead: The risk of neurologic complications due to COVID-19. Neurology: Clinical Practice. 2020. [Published online 9 April 2020]. doi:10.1212/CPJ.00000000000 00836
Galougahi M, Ghorbani J, Bakhshayeshkaram M, Safavi Naeini A, Haseli S. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: the first report. Academic Radiology. 2020. [Ahead of print, published online 13 April 2020]. doi:10.1016/j.acra.2020.04.002
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol.2020;77(6):683–690. doi:10.1001/ jamaneurol.2020.1127
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 Jul;7(7):611-627.
Orsini A, Corsi M, Santangelo A, Riva A, Peroni D, Foiadelli T, Savasta S, Striano P. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients. Neurol Sci. 2020 Sep; 41(9):2353-2366.
Needham EJ, Chou SH, Coles AJ, Menon DK. Neurological Implications of COVID-19 Infections. Neurocrit Care. 2020 Jun; 32(3):667-671.
González-Sanguino C, Ausín B, Castellanos MÁ, Saiz J, López-Gómez A, Ugidos C, Muñoz M. Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun. 2020 Jul; 87:172-176.
Nalleballe K, Reddy Onteddu S, Sharma R, Dandu V, Brown A, Jasti M, Yadala S, Veerapaneni K, Siddamreddy S, Avula A, Kapoor N, Mudassar K, Kovvuru S. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun. 2020 Aug; 88:71-74.
Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, Antel JP, Mowla A. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020 Oct 15; 417:117085.
Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, Al-Shahi Salman R, Menon DK, Nicholson TR, Benjamin LA, Carson A, Smith C, Turner MR, Solomon T, Kneen R, Pett SL, Galea I, Thomas RH, Michael BD. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. CoroNerve Study Group.Lancet Psychiatry. 2020 Oct; 7(10):875-882.
Baig AM. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement. ACS Chem Neurosci. 2020 May 6; 11(9):1204-1205.